Textiles Press Releases
SEE OTHER BRANDS

Your best source on the textile industry news from the world

Textiles Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.

Press releases published on April 23, 2025

Plexus Announces Fiscal Second Quarter Financial Results

Plexus Announces Fiscal Second Quarter Financial Results

NEENAH, WI, April 23, 2025 (GLOBE NEWSWIRE) -- Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 29, 2025, and guidance for our fiscal third quarter ending June 28, 2025. Reports fiscal second quarter …

Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology

Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology

Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the …

TFI International Reports on Shareholders’ Voting Results for the Election of Directors

TFI International Reports on Shareholders’ Voting Results for the Election of Directors

MONTREAL, April 23, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, held its Annual Meeting of shareholders earlier today. All candidates …

TFI International communique les résultats du vote des actionnaires pour l’élection des administrateurs

TFI International communique les résultats du vote des actionnaires pour l’élection des administrateurs

MONTRÉAL, 23 avr. 2025 (GLOBE NEWSWIRE) -- Le conseil d’administration de TFI International Inc. (NYSE et TSX : TFII), un chef de file nord-américain du secteur du transport et de la logistique, a tenu son assemblée générale annuelle des actionnaires plus …

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with …

Zeneara Under Review: Natural Mute Button Method Helps Silence Tinnitus Ringing

Zeneara Under Review: Natural Mute Button Method Helps Silence Tinnitus Ringing

New York City, April 23, 2025 (GLOBE NEWSWIRE) -- Introduction: The Silent Struggle with Tinnitus The Unseen Burden Millions Carry Tinnitus, commonly described as a persistent ringing, buzzing, or hissing sound in the ears, is more than just an annoyance— …

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

Silvaco Announces Date of First Quarter 2025 Financial Results Conference Call

SANTA CLARA, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and …

Artesian Water Company Announces the Hiring of Deirdre S. Smith, P.E., as Director of Planning

Artesian Water Company Announces the Hiring of Deirdre S. Smith, P.E., as Director of Planning

NEWARK, Del., April 23, 2025 (GLOBE NEWSWIRE) -- Artesian Water Company, a subsidiary of Artesian Resources Corporation (Nasdaq: ARTNA), announces that Deirdre S. Smith, P.E., has joined the Company as Director of Planning. In her new role, Ms. Smith is …

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Corvus Pharmaceuticals to Present New Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on May 8, 2025

Data from Cohorts 1-3 of trial to be presented in an oral session and poster at the Society for Investigative Dermatology (SID) 2025 Annual Meeting Company to discuss data on its first quarter 2025 business update conference call and webcast scheduled for …

First Watch Announces Flagship Location in Heart of Downtown Boston

First Watch Announces Flagship Location in Heart of Downtown Boston

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading daytime restaurant serving breakfast, brunch and lunch, announced it will open its first downtown Boston location in …

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

Churchill Downs Incorporated Announces Updates on Capital Projects for Churchill Downs Racetrack

LOUISVILLE, Ky., April 23, 2025 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) (Nasdaq: CHDN) announced today renovations of the existing Finish Line Suites and The Mansion at Churchill Downs Racetrack with expected completion in …

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

 ACV to Report First Quarter 2025 Financial Results on May 7, 2025

ACV to Report First Quarter 2025 Financial Results on May 7, 2025

BUFFALO, N.Y., April 23, 2025 (GLOBE NEWSWIRE) -- ACV (NYSE: ACVA), a leading digital automotive marketplace and data services partner for dealers and commercial clients, announced today that the Company will report first quarter 2025 financial results …

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025

WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research …

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

Dynagas LNG Partners LP Declares Cash Distribution on Its Series A Preferred Units

ATHENS, Greece, April 23, 2025 (GLOBE NEWSWIRE) -- Dynagas LNG Partners LP (the “Partnership”) (NYSE: “DLNG”), an owner and operator of LNG carriers, today announced that its Board of Directors has declared a cash distribution of $0.5625 per unit on its …

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

Zentalis Pharmaceuticals Announces Poster Presentation at 2025 ASCO Annual Meeting

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective on January 31, 2025, the company issued inducement awards …

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

Cardiff Oncology Announces a Second Patent for the Treatment of mCRC for Bev-Naïve Patients

SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the United States Patent and …

TFI International Announces 2025 First Quarter Results

TFI International Announces 2025 First Quarter Results

First quarter operating income of $114.6 million compares to $151.6 million in the same prior year quarter First quarter net income of $56.0 million compares to $92.8 million in Q1 2024, while adjusted net income1 of $64.2 million compares to $105.5 …

TFI International communique ses résultats du premier trimestre 2025

TFI International communique ses résultats du premier trimestre 2025

Le bénéfice opérationnel du premier trimestre de 114,6 M$ se compare à celui de 151,6 M$ au trimestre correspondant de l’exercice précédent. Le bénéfice net du premier trimestre de 56,0 M$ se compare à celui du premier trimestre de 2024 de 92,8 M$, tandis …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service